Beijing Tinavi Medical Gains China Rights to Spineway's Spinal Devices

Beijing Tinavi Medical Technologies in-licensed China rights to spinal implants and surgical devices made by Spineway of Lyon, France. Tinavi made a $1.5 million investment in Spineway for five-year exclusive distribution rights, giving them a 9% stake in Spineway. The shares also have warrants attached that would raise Tinavi's ownership in Spineway to 17% in exchange for an additional $1.7 million. Tinavi markets a robotic surgical device, Phecda™, in China that is used for trauma and spine surgeries. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.